Compare AJANTA PHARMA with FDC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs FDC - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA FDC AJANTA PHARMA/
FDC
 
P/E (TTM) x 28.3 22.8 124.1% View Chart
P/BV x 7.0 4.4 158.6% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 AJANTA PHARMA   FDC
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
FDC
Mar-18
AJANTA PHARMA/
FDC
5-Yr Chart
Click to enlarge
High Rs1,422319 445.7%   
Low Rs898164 547.3%   
Sales per share (Unadj.) Rs233.561.6 378.8%  
Earnings per share (Unadj.) Rs44.09.9 441.9%  
Cash flow per share (Unadj.) Rs52.212.0 435.9%  
Dividends per share (Unadj.) Rs9.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs255.173.2 348.6%  
Shares outstanding (eoy) m88.02174.40 50.5%   
Bonus/Rights/Conversions BBBB-  
Price / Sales ratio x5.03.9 126.8%   
Avg P/E ratio x26.424.3 108.7%  
P/CF ratio (eoy) x22.220.2 110.2%  
Price / Book Value ratio x4.53.3 137.8%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m102,08142,118 242.4%   
No. of employees `0006.85.5 122.9%   
Total wages/salary Rs m4,3072,167 198.8%   
Avg. sales/employee Rs Th3,022.61,943.7 155.5%   
Avg. wages/employee Rs Th633.4391.7 161.7%   
Avg. net profit/employee Rs Th569.1313.7 181.4%   
INCOME DATA
Net Sales Rs m20,55410,751 191.2%  
Other income Rs m211510 41.4%   
Total revenues Rs m20,76511,260 184.4%   
Gross profit Rs m5,6642,267 249.9%  
Depreciation Rs m721351 205.1%   
Interest Rs m1214 82.9%   
Profit before tax Rs m5,1432,411 213.3%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,273671 189.7%   
Profit after tax Rs m3,8701,735 223.0%  
Gross profit margin %27.621.1 130.7%  
Effective tax rate %24.827.8 88.9%   
Net profit margin %18.816.1 116.7%  
BALANCE SHEET DATA
Current assets Rs m11,8127,213 163.8%   
Current liabilities Rs m3,7762,104 179.5%   
Net working cap to sales %39.147.5 82.3%  
Current ratio x3.13.4 91.2%  
Inventory Days Days7754 142.0%  
Debtors Days Days8228 294.3%  
Net fixed assets Rs m14,3986,865 209.7%   
Share capital Rs m175175 100.1%   
"Free" reserves Rs m22,27712,586 177.0%   
Net worth Rs m22,45212,761 175.9%   
Long term debt Rs m76 110.0%   
Total assets Rs m26,96215,041 179.3%  
Interest coverage x444.3173.2 256.5%   
Debt to equity ratio x00 62.5%  
Sales to assets ratio x0.80.7 106.7%   
Return on assets %14.411.6 123.8%  
Return on equity %17.213.6 126.8%  
Return on capital %23.019.0 121.1%  
Exports to sales %012.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,6821,889 565.5%   
Fx outflow Rs m2,1020-   
Net fx Rs m8,5801,889 454.2%   
CASH FLOW
From Operations Rs m3,7481,498 250.1%  
From Investments Rs m-2,228201 -1,107.9%  
From Financial Activity Rs m-1,475-1,694 87.0%  
Net Cashflow Rs m4510 438.8%  

Share Holding

Indian Promoters % 73.8 68.9 107.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 4.7 33.0%  
FIIs % 7.6 7.5 101.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 19.0 89.5%  
Shareholders   20,968 23,730 88.4%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUVEN LIFE SCIENCES  NEULAND LABS  PIRAMAL ENTERPRISES  TTK HEALTHCARE  SUN PHARMA  

Compare AJANTA PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends at Record High; Tata Motors and Adani Ports Among Top Nifty Gainers(Closing)

Indian share markets extended gains to the second day today and ended at record-high levels with Nifty ending above 14,600-mark.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (3QFY20); Net Profit Up 67.7% (Quarterly Result Update)

Feb 10, 2020 | Updated on Feb 10, 2020

For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jan 20, 2021 03:36 PM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS